Environmental Impact Acquisition Corp. (NASDAQ:ENVI) announced this afternoon that its shareholders have approved its combination with biotech firm GreenLight in a special meeting held yesterday.
The 8-K filing did not disclose redemption amounts, but ENVI closed yesterday at $8.57. A total of 20,879,590 shares of ENVI’s common stock, representing 80.69% of the shareholders, were present at yesterday’s special meeting with 78.6% voting in favor of the combination.
The SPAC announced in late November that it added $19 million to the PIPE for its deal, totaling $124 million in gross proceeds. The additional $19 million included a $10 million strategic investment from Serum Life Sciences Ltd, a subsidiary of Serum Institute of India Pvt. Ltd, and was made under the same terms as the $105 million common stock PIPE investment that ENVI and GreenLight announced as part of their proposed business combination.
Investors include Serum Life Sciences, Fall Line Capital, Viceroy Capital, S2G Ventures, Cormorant Asset Management, Morningside Venture Investments, Hudson Bay Capital, BNP Paribas Ecosystem Restoration Fund, The Jeremy and Hannelore Grantham Environmental Trust, Continental Grain Company, Pura Vida Investments LLC, Xeraya Capital, and MLS Fund II/Spruce.
In connection with the closing, the company will change its name to GreenLight Biosciences Holdings, and the combined company’s common stock and public warrants are expected to trade on the Nasdaq beginning tomorrow, February 3, 2022, under the ticker symbols “GRNA” and “GRNA.WS,” respectively.
Environmental Impact originally announced its $1.2 billion deal with GreenLight last year on August 10. Massachusetts-based GreenLight is developing a biomanufacturing platform for commercializing ribonucleic acid (RNA) products for both agricultural and human health applications.
ADVISORS
- SVB Leerink LLC and Credit Suisse Securities (USA) LLC are acting as financial and capital markets advisors to GreenLight and co-placement agents on the PIPE transaction.
- Foley Hoag LLP is acting as the legal advisor to GreenLight.
- Canaccord Genuity is acting as the financial advisor.
- Latham & Watkins LLP is acting as legal advisor to Environmental Impact Acquisition Corp.
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...
Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...
Despite a week of general pull-backs in the market, fintech firm Ibotta (NYSE:IBTA) nonetheless took the dive and had a good week debuting via a traditional IPO in the choppy waters. The company, which provides app-based consumer cashback discounts on purchases, priced its IPO at $88, above its proposed range of $76 to $84, and...
At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...